Eyenovia (EYEN) Revenue & Revenue Breakdown
Eyenovia Revenue Highlights
Latest Revenue (Y)
$57.34K
Latest Revenue (Q)
$14.72K
Eyenovia Revenue by Period
Eyenovia Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $57.34K | 1414.02% |
| 2023-12-31 | $3.79K | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2021-12-31 | $14.00M | 600.00% |
| 2020-12-31 | $2.00M | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | - |
Eyenovia generated $57.34K in revenue during NA 2024, up 1414.02% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Eyenovia Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $14.72K | -47.60% |
| 2024-12-31 | $28.09K | 1628.80% |
| 2024-09-30 | $1.63K | -92.82% |
| 2024-06-30 | $22.63K | 353.13% |
| 2024-03-31 | $4.99K | 92.85% |
| 2023-12-31 | $2.59K | 116.11% |
| 2023-09-30 | $1.20K | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-12-31 | $10.00M | 100.00% |
| 2021-09-30 | - | -100.00% |
| 2021-06-30 | $2.00M | - |
| 2021-03-31 | $2.00M | - |
| 2020-12-31 | $2.00M | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | - |
Eyenovia generated $14.72K in revenue during Q1 2025, up -47.60% compared to the previous quarter, and up 568.56% compared to the same period a year ago.
Eyenovia Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ADAP | Adaptimmune Therapeutics | $178.03M | $7.29M |
| FGEN | FibroGen | $29.62M | $1.35M |
| GBIO | Generation Bio | $19.89M | $765.00K |
| VRCA | Verrica Pharmaceuticals | $7.57M | $12.70M |
| XFOR | X4 Pharmaceuticals | $2.56M | $28.81M |
| EYEN | Eyenovia | $57.34K | $14.72K |
| PDSB | PDS Bio | - | - |
| IOBT | IO Biotech | - | - |
| MURA | Mural Oncology | - | - |
| JSPR | Jasper Therapeutics | - | - |
| PSTV | Plus Therapeutics | - | $1.06M |